![Fredrik Dahl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fredrik Dahl
Directeur/Bestuurslid bij
DEVYSER DIAGNOSTICS AB
Vermogen: 444 692 $ op 31-05-2026
Profiel
Fredrik Dahl is the founder of Colibri Ventures AB,Pixelgen Technologies AB. Currently, Dr. Dahl is Chairman at Faboss Invest AB, Director at Devyser Diagnostics AB starting 2025, Director at Nucleus Capital AB, and Director at Llya Pharma AB. Formerly, Dr. Dahl was Director at Moligo Technologies AB, Chief Technology Officer at Halo Genomics AB, and Chief Technology Officer at Vanadis Diagnostics AB. Education includes undergraduate and doctorate degrees from the University of Uppsala.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 07-05-2025 | 44.150 ( 0,27% ) | 444 692 $ | 31-05-2026 |
Actieve functies van Fredrik Dahl
| Bedrijven | Functie | Begin |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Directeur/Bestuurslid | 01-01-2021 |
Colibri Ventures AB | Oprichter | - |
Faboss Invest AB | Voorzitter | - |
Nucleus Capital AB | Directeur/Bestuurslid | - |
Pixelgen Technologies AB
 Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Oprichter | - |
Llya Pharma AB | Directeur/Bestuurslid | - |
Eerdere bekende functies van Fredrik Dahl
| Bedrijven | Functie | Einde |
|---|---|---|
Vanadis Diagnostics AB
 Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Hoofd Techniek/Wetenschap/O&O | - |
Halo Genomics AB
 Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Hoofd Techniek/Wetenschap/O&O | - |
Moligo Technologies AB
 Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Directeur/Bestuurslid | - |
Opleiding van Fredrik Dahl
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Develops products for preparation of DNA for the next generation sequencing platforms | Health Services |
Devyser Diagnostics AB
 Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Vanadis Diagnostics AB
Vanadis Diagnostics AB Miscellaneous Commercial ServicesCommercial Services Develops novel solution for non-invasive prenatal testing | Commercial Services |
Colibri Ventures AB | |
Faboss Invest AB | |
Moligo Technologies AB
Moligo Technologies AB BiotechnologyHealth Technology Engages in producing ultrapure DNA | Health Technology |
Pixelgen Technologies AB
Pixelgen Technologies AB Packaged SoftwareTechnology Services Develops bio-analytical tools for immune cell surface protein | Technology Services |
Nucleus Capital AB | |
Llya Pharma AB |
